Please login to the form below

Not currently logged in

Biogen files Tecfidera follow-up in the US


Improved GI tolerability is major selling point

Novartis withdraws EU filing for canakinumab

Novartis Basel WebFurther setback for cardiovascular blockbuster potential

NICE appraisal fees to be introduced despite opposition

NICE (National for Health and Clinical Excellence)Concessions made for small companies

‘No deal’ Brexit could see pharmacists take lead amid drug shortages

pharmacistGovernment steps up preparations as Brexit day nears

FDA clears Sandoz and Pear’s Opioid Use Disorder app

The app incorporates CBT to improve high relapse rates

As May delays, industry warns again of ‘no-deal’ Brexit

Theresa May CamerasBrussels offers warm words, but no renegotiation

FDA fast tracks Novartis’ SMA gene therapy

Novartis HQGene therapy could be approved in first half of 2019, will challenge Biogen's Spinraza

NICE U-turn sees Opdivo backed as adjuvant therapy for skin cancer

OpdivoBut it is only available via the CDF for now

Shire’s angioedema drug Takhzyro claims EU approval

ShireApproval shortly follows a green light in the US

Brexit‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Latest regulatory appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...